News

07 January 2020

Talcum Powder and ovarian cancer: What’s the story?

06 December 2019

Scotland follows England, Wales and Northern Ireland in making olaparib available to all women with hereditary ovarian cancer

27 November 2019

"We had lots of laughs and bonded with each other as we walked through the busy roads in London"

On October 18th, Natwest walked the London Marathon Route to raise funds for Ovarian Cancer Action. One member of the team, Adam, shares his experience.

13 November 2019

One Cancer Voice: A manifesto for people living with cancer

Ovarian Cancer Action is one of 28 cancer charities launching a joint manifesto on behalf of cancer patients across the UK today

29 October 2019

Ovarian Cancer Action launches a campaign for the next generation

29 October 2019

OCA invests £900,000 in new research to create better ovarian cancer treatments

11 October 2019

A new treatment option for women with relapsed ovarian cancer

There was positive news today for women with relapsed ovarian cancer, with the announcement that a new treatment, rucaparib (also known as Rubraca), will now be available on the NHS.

03 October 2019

Beyoncé’s father reveals family’s BRCA link following his breast cancer diagnosis

This week, Matthew Knowles – father of singers Beyoncé and Solange Knowles – shone a different light on both breast cancer and BRCA when he revealed he was recently diagnosed with breast cancer and carries a mutation in his BRCA2 gene.

26 July 2019

Personalised treatment becomes a reality for women with hereditary ovarian cancer

In the news today, PARP inhibitor olapoarib is now available to women with newly diagnosed BRCA-mutated ovarian, fallopian and peritoneal cancer following first-line chemotherapy.

22 July 2019

Healthcare professionals call for tighter restrictions on at-home genetic testing kits

Senior doctors have called for stricter regulations around consumer genetic testing kits such as 23andMe and AncestryDNA.

12 July 2019

New immunotherapy trial for patients with advanced cancer

Funding has been granted to a study where patients with advanced cancer will test a new therapy called bermekibab, aimed at reducing their symptoms and improving their quality of life.

05 July 2019

Ovarian Cancer Action awarded ‘Charity, Professional or Patient Association of the Year’ at The Communiqué Awards

03 July 2019

Obesity as a risk factor for ovarian cancer

Around 7% of ovarian cancer cases are caused by being overweight or obese and 1% of cases are caused by smoking. However, whilst these figures highlight that it is important to lead a healthy lifestyle, they also show that the majority of ovarian cancer cases are unrelated to obesity.

20 June 2019

Is there a new ovarian cancer screening tool on the horizon?

In the news today, new research from Uppsala University in Sweden has been reported as a potential new blood test to detect ovarian cancer.

05 June 2019

166,000 people in UK population unaware they have Lynch syndrome

In the week that saw the passing of Dr Henry Lynch, a scientist renowned for his work on hereditary cancer, NHS Wales will begin offering genetic testing for Lynch syndrome to all bowel cancer patients. We reflect on the significance of Dr Lynch’s work and how his legacy is continuing to save lives.

16 May 2019

Politicians in England, Wales and Scotland unite behind our World Ovarian Cancer Day campaign

Ovarian cancer is a complicated disease – it’s difficult to diagnose and challenging to treat – and it doesn’t always get the attention it deserves. This year we were delighted to see politicians in England, Wales and Scotland helping put a spotlight on the disease, uniting behind our World Ovarian Cancer Day campaign for earlier diagnosis.

04 April 2019